A former director of biopharmaceutical company, Chinook Therapeutics, has been sentenced to prison for insider trading related to the company’s $3.2 billion sale to Novartis in 2023, a fraud detected through data analysis by the SEC.
SEC
Posted inCryptocurrency and Digital Assets
The SEC’s crypto taxonomy changes everything. Pending enforcement targets should act now
The SEC’s Division of Corporation Finance published a 68-page interpretive release in March that, for the first time, defines what is and is not a security in the digital asset space.
Posted inWhistleblowers
Exclusive: Former Docusign executive sues company for whistleblower retaliation
A former Docusign executive alleged in a federal whistleblower lawsuit that the software company constructively discharged her after she blew the whistle on the company’s mishandling of sensitive data for customers, including Bank of America and Wells Fargo.
Posted inSurveys & Benchmarking
ITM survey: Some organizations pull DEI programs—and some keep them—under feds’ DEI reversal, compliance officers report
Nearly four in 10 compliance teams have made it a priority to review risks related to their traditional DEI efforts and other programs in the face of the Trump administration’s unprecedented broadsides against the programs.
Posted inESG/Social Responsibility
CW National: Peirce confirms SEC climate rule rescission proposal being reviewed
Commissioner Hester Peirce had raised concerns about the rule and views the U.S.’s pullback on ESG regulations as a competitive edge over other countries.
Posted inArtificial Intelligence
U.K. joins global trend for AI-enabled regulatory supervision
The U.K. financial regulator is expanding its remit and planning to deploy AI to manage its increased workload. This is part of a global trend and has significant compliance implications.
Posted inRegulatory Enforcement
SEC enforcements dropped in 2025
The Securities and Exchange Commission (SEC) pursued fewer enforcement actions in 2025—an intentional outcome, the commission said.
